{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T06:08:15Z","timestamp":1775887695536,"version":"3.50.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["571408"],"award-info":[{"award-number":["571408"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["632701"],"award-info":[{"award-number":["632701"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001102","name":"Cancer Council NSW","doi-asserted-by":"publisher","award":["RG 20-03"],"award-info":[{"award-number":["RG 20-03"]}],"id":[{"id":"10.13039\/501100001102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001102","name":"Cancer Council NSW","doi-asserted-by":"publisher","award":["RG 20-03"],"award-info":[{"award-number":["RG 20-03"]}],"id":[{"id":"10.13039\/501100001102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>MiR-181 expression levels increased in hepatocellular carcinoma (HCC) compared to non-cancerous tissues. MiR-181 has been widely reported as a possible driver of tumourigenesis but also acts as a tumour suppressor. In addition, the miR-181 family regulates the development and function of immune and vascular cells, which play vital roles in the progression of tumours. More complicatedly, many genes have been identified as miR-181 targets to mediate the effects of miR-181. However, the role of miR-181 in the development of primary tumours remains largely unexplored. We aimed to examine the function of miR-181 and its vital mediators in the progression of diethylnitrosamine-induced primary liver cancers in mice. The size of liver tumours was significantly reduced by 90% in global (GKO) or liver-specific (LKO) 181ab1 knockout mice but not in hematopoietic and endothelial lineage-specific knockout mice, compared to WT mice. In addition, the number of tumours was significantly reduced by 50% in GKO mice. Whole-genome RNA-seq analysis and immunohistochemistry showed that epithelial-mesenchymal transition was partially reversed in GKO tumours compared to WT tumours. The expression of CBX7, a confirmed miR-181 target, was up-regulated in GKO compared to WT tumours. Stable CBX7 expression was achieved with an AAV\/Transposase Hybrid-Vector System and up-regulated CBX7 expression inhibited liver tumour progression in WT mice. Hepatic CBX7 deletion restored the progression of LKO liver tumours. MiR-181a expression was the lowest and CBX7 expression the highest in iClust2 and 3 subclasses of human HCC compared to iClust1. Gene expression profiles of GKO tumours overlapped with low-proliferative peri-portal-type HCCs. Liver-specific loss of miR-181ab1 inhibited primary liver tumour progression via up-regulating CBX7 expression, but tumour induction requires both hepatic and non-hepatic miR-181. Also, miR-181ab1-deficient liver tumours may resemble low-proliferative periportal-type human HCC.<\/jats:p>\n                <jats:p><jats:bold>Graphical abstract<\/jats:bold><\/jats:p>","DOI":"10.1007\/s00018-022-04452-6","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T15:02:54Z","timestamp":1658502174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Liver-specific deletion of miR-181ab1 reduces liver tumour progression via upregulation of CBX7"],"prefix":"10.1007","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0339-5880","authenticated-orcid":false,"given":"Jinbiao","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jade A.","family":"Boland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ngan Ching","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessamy C.","family":"Tiffen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Bertolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leszek","family":"Lisowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian E.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew A.","family":"Vadas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad","family":"El-Omar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer R.","family":"Gamble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey W.","family":"McCaughan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"issue":"15","key":"4452_CR1","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A (2019) Hepatocellular carcinoma. N Engl J Med 380(15):1450\u20131462","journal-title":"N Engl J Med"},{"issue":"6","key":"4452_CR2","doi-asserted-by":"crossref","first-page":"100167","DOI":"10.1016\/j.jhepr.2020.100167","volume":"2","author":"MG Fern\u00e1ndez-Barrena","year":"2020","unstructured":"Fern\u00e1ndez-Barrena MG, Arechederra M, Colyn L, Berasain C, Avila MA (2020) Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg. JHEP Rep 2(6):100167","journal-title":"JHEP Rep"},{"key":"4452_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15052","author":"TH Su","year":"2021","unstructured":"Su TH, Hsu SJ, Kao JH (2021) Paradigm shift in the treatment options of hepatocellular carcinoma. Liver Int. https:\/\/doi.org\/10.1111\/liv.15052","journal-title":"Liver Int"},{"issue":"7","key":"4452_CR4","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","volume":"169","author":"Cancer Genome Atlas Research Network Electronic address, w. b. e.; Cancer Genome Atlas Research, N.","year":"2017","unstructured":"Cancer Genome Atlas Research Network Electronic address, w. b. e.; Cancer Genome Atlas Research, N. (2017) Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell 169(7):1327-1341.e23","journal-title":"Cell"},{"issue":"1","key":"4452_CR5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00432-021-03826-w","volume":"148","author":"A Raja","year":"2022","unstructured":"Raja A, Haq F (2022) Molecular classification of hepatocellular carcinoma: prognostic importance and clinical applications. J Cancer Res Clin Oncol 148(1):15\u201329","journal-title":"J Cancer Res Clin Oncol"},{"issue":"11","key":"4452_CR6","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.4254\/wjh.v13.i11.1568","volume":"13","author":"A Natu","year":"2021","unstructured":"Natu A, Singh A, Gupta S (2021) Hepatocellular carcinoma: understanding molecular mechanisms for defining potential clinical modalities. World J Hepatol 13(11):1568\u20131583","journal-title":"World J Hepatol"},{"issue":"2","key":"4452_CR7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jhep.2019.08.017","volume":"72","author":"S Rebouissou","year":"2020","unstructured":"Rebouissou S, Nault JC (2020) Advances in molecular classification and precision oncology in hepatocellular carcinoma. J Hepatol 72(2):215\u2013229","journal-title":"J Hepatol"},{"issue":"5","key":"4452_CR8","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.neo.2021.04.001","volume":"23","author":"A Gaza","year":"2021","unstructured":"Gaza A, Fritz V, Malek L, Wormser L, Treiber N, Danner J, Kremer AE, Thasler WE, Siebler J, Meister G, Neurath MF, Hellerbrand C, Bosserhoff AK, Dietrich P (2021) Identification of novel targets of miR-622 in hepatocellular carcinoma reveals common regulation of cooperating genes and outlines the oncogenic role of zinc finger CCHC-type containing 11. Neoplasia 23(5):502\u2013514","journal-title":"Neoplasia"},{"issue":"16","key":"4452_CR9","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.3390\/cancers13164237","volume":"13","author":"E Wolinska","year":"2021","unstructured":"Wolinska E, Skrzypczak M (2021) Epigenetic changes affecting the development of hepatocellular carcinoma. Cancers (Basel) 13(16):4237","journal-title":"Cancers (Basel)"},{"key":"4452_CR10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.omtn.2021.04.021","volume":"25","author":"D Rong","year":"2021","unstructured":"Rong D, Sun G, Wu F, Cheng Y, Sun G, Jiang W, Li X, Zhong Y, Wu L, Zhang C, Tang W, Wang X (2021) Epigenetics: roles and therapeutic implications of non-coding RNA modifications in human cancers. Mol Ther Nucleic Acids 25:67\u201382","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"4452_CR11","doi-asserted-by":"crossref","first-page":"7967","DOI":"10.1038\/s41598-018-26360-1","volume":"8","author":"SV Koduru","year":"2018","unstructured":"Koduru SV, Leberfinger AN, Kawasawa YI, Mahajan M, Gusani NJ, Sanyal AJ, Ravnic DJ (2018) Non-coding RNAs in various stages of liver disease leading to hepatocellular carcinoma: differential expression of miRNAs, piRNAs, lncRNAs, circRNAs, and sno\/mt-RNAs. Sci Rep 8(1):7967","journal-title":"Sci Rep"},{"issue":"2","key":"4452_CR12","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/nar\/gkab1256","volume":"50","author":"A Kilikevicius","year":"2022","unstructured":"Kilikevicius A, Meister G, Corey DR (2022) Reexamining assumptions about miRNA-guided gene silencing. Nucleic Acids Res 50(2):617\u2013634","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"4452_CR13","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1002\/jcp.26545","volume":"233","author":"L Sanna","year":"2018","unstructured":"Sanna L, Marchesi I, Melone MAB, Bagella L (2018) The role of enhancer of zeste homolog 2: from viral epigenetics to the carcinogenesis of hepatocellular carcinoma. J Cell Physiol 233(9):6508\u20136517","journal-title":"J Cell Physiol"},{"issue":"3","key":"4452_CR14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole R, Slack FJ (2017) MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov 16(3):203\u2013222","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"4452_CR15","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.3390\/ijms21062092","volume":"21","author":"A Indrieri","year":"2020","unstructured":"Indrieri A, Carrella S, Carotenuto P, Banfi S, Franco B (2020) The pervasive role of the miR-181 family in development, neurodegeneration, and cancer. Int J Mol Sci 21(6):2092","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4452_CR16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/liv.12517","volume":"35","author":"J Brockhausen","year":"2015","unstructured":"Brockhausen J, Tay SS, Grzelak CA, Bertolino P, Bowen DG, d\u2019Avigdor WM, Teoh N, Pok S, Shackel N, Gamble JR, Vadas M, McCaughan GW (2015) miR-181a mediates TGF-beta-induced hepatocyte EMT and is dysregulated in cirrhosis and hepatocellular cancer. Liver Int 35(1):240\u2013253","journal-title":"Liver Int"},{"issue":"1","key":"4452_CR17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3892\/br.2013.199","volume":"2","author":"J Liu","year":"2014","unstructured":"Liu J, Shi W, Wu C, Ju J, Jiang J (2014) miR-181b as a key regulator of the oncogenic process and its clinical implications in cancer (Review). Biomed Rep 2(1):7\u201311","journal-title":"Biomed Rep"},{"issue":"2","key":"4452_CR18","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.22989","volume":"50","author":"J Ji","year":"2009","unstructured":"Ji J, Yamashita T, Budhu A, Forgues M, Jia HL, Li C, Deng C, Wauthier E, Reid LM, Ye QH, Qin LX, Yang W, Wang HY, Tang ZY, Croce CM, Wang XW (2009) Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology 50(2):472\u2013480","journal-title":"Hepatology"},{"issue":"12","key":"4452_CR19","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/onc.2009.468","volume":"29","author":"B Wang","year":"2010","unstructured":"Wang B, Hsu SH, Majumder S, Kutay H, Huang W, Jacob ST, Ghoshal K (2010) TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene 29(12):1787\u20131797","journal-title":"Oncogene"},{"issue":"11","key":"4452_CR20","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1016\/j.celrep.2020.02.077","volume":"30","author":"CX Lim","year":"2020","unstructured":"Lim CX, Lee B, Geiger O, Passegger C, Beitzinger M, Romberger J, Stracke A, H\u00f6genauer C, Stift A, Stoiber H, Poidinger M, Zebisch A, Meister G, Williams A, Flavell RA, Henao-Mejia J, Strobl H (2020) miR-181a modulation of ERK-MAPK signaling sustains DC-SIGN expression and limits activation of monocyte-derived dendritic cells. Cell Rep 30(11):3793-3805.e5","journal-title":"Cell Rep"},{"issue":"18","key":"4452_CR21","doi-asserted-by":"crossref","first-page":"7407","DOI":"10.1073\/pnas.1221984110","volume":"110","author":"N Zietara","year":"2013","unstructured":"Zietara N, Lyszkiewicz M, Witzlau K, Naumann R, Hurwitz R, Langemeier J, Bohne J, Sandrock I, Ballmaier M, Weiss S, Prinz I, Krueger A (2013) Critical role for miR-181a\/b-1 in agonist selection of invariant natural killer T cells. Proc Natl Acad Sci U S A 110(18):7407\u20137412","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4452_CR22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10555-017-9714-9","volume":"37","author":"C Pop-Bica","year":"2018","unstructured":"Pop-Bica C, Pintea S, Cojocneanu-Petric R, Del Sal G, Piazza S, Wu ZH, Alencar AJ, Lossos IS, Berindan-Neagoe I, Calin GA (2018) MiR-181 family-specific behavior in different cancers: a meta-analysis view. Cancer Metastasis Rev 37(1):17\u201332","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"4452_CR23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.stem.2011.12.004","volume":"10","author":"A O'Loghlen","year":"2012","unstructured":"O\u2019Loghlen A, Munoz-Cabello AM, Gaspar-Maia A, Wu HA, Banito A, Kunowska N, Racek T, Pemberton HN, Beolchi P, Lavial F, Masui O, Vermeulen M, Carroll T, Graumann J, Heard E, Dillon N, Azuara V, Snijders AP, Peters G, Bernstein E, Gil J (2012) MicroRNA regulation of Cbx7 mediates a switch of Polycomb orthologs during ESC differentiation. Cell Stem Cell 10(1):33\u201346","journal-title":"Cell Stem Cell"},{"issue":"6","key":"4452_CR24","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.ajpath.2020.02.011","volume":"190","author":"YF Pei","year":"2020","unstructured":"Pei YF, He Y, Hu LZ, Zhou B, Xu HY, Liu XQ (2020) The crosstalk between lncRNA-SNHG7\/miRNA-181\/cbx7 modulates malignant character in lung adenocarcinoma. Am J Pathol 190(6):1343\u20131354","journal-title":"Am J Pathol"},{"issue":"7","key":"4452_CR25","doi-asserted-by":"crossref","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie-du-Sert","year":"2020","unstructured":"Percie-du-Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, Emerson M, Garner P, Holgate ST, Howells DW, Karp NA, Lazic SE, Lidster K, MacCallum CJ, Macleod M, Pearl EJ, Petersen OH, Rawle F, Reynolds P, Rooney K, Sena ES, Silberberg SD, Steckler T, Wurbel H (2020) The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol 18(7):e3000410","journal-title":"PLoS Biol"},{"key":"4452_CR26","doi-asserted-by":"publisher","DOI":"10.7554\/elife.21064","author":"M Endoh","year":"2017","unstructured":"Endoh M, Endo TA, Shinga J, Hayashi K, Farcas A, Ma KW, Ito S, Sharif J, Endoh T, Onaga N, Nakayama M, Ishikura T, Masui O, Kessler BM, Suda T, Ohara O, Okuda A, Klose R, Koseki H (2017) PCGF6-PRC1 suppresses premature differentiation of mouse embryonic stem cells by regulating germ cell-related genes. Elife. https:\/\/doi.org\/10.7554\/elife.21064","journal-title":"Elife"},{"issue":"1","key":"4452_CR27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tibs.2015.11.005","volume":"41","author":"T Kondo","year":"2016","unstructured":"Kondo T, Ito S, Koseki H (2016) Polycomb in transcriptional phase transition of developmental genes. Trends Biochem Sci 41(1):9\u201319","journal-title":"Trends Biochem Sci"},{"key":"4452_CR28","doi-asserted-by":"crossref","first-page":"166335","DOI":"10.1016\/j.bbadis.2021.166335","volume":"1868","author":"J Chen","year":"2021","unstructured":"Chen J, Cheng NC, Boland JA, Liu K, Kench JG, Watkins DN, Ferreira-Gonzalez S, Forbes SJ, McCaughan GW (2021) Deletion of kif3a in CK19 positive cells leads to primary cilia loss, biliary cell proliferation and cystic liver lesions in TAA-treated mice. Biochim Biophys Acta Mol Basis Dis 1868:166335","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"21","key":"4452_CR29","doi-asserted-by":"crossref","first-page":"15635","DOI":"10.18632\/oncotarget.24583","volume":"9","author":"J Chen","year":"2018","unstructured":"Chen J, Qi Y, Zhao Y, Kaczorowski D, Couttas TA, Coleman PR, Don AS, Bertolino P, Gamble JR, Vadas MA, Xia P, McCaughan GW (2018) Deletion of sphingosine kinase 1 inhibits liver tumorigenesis in diethylnitrosamine-treated mice. Oncotarget 9(21):15635\u201315649","journal-title":"Oncotarget"},{"key":"4452_CR30","volume":"124","author":"D Kaltenecker","year":"2019","unstructured":"Kaltenecker D, Themanns M, Mueller KM, Spirk K, Golob-Schwarzl N, Friedbichler K, Kenner L, Haybaeck J, Moriggl R (2019) STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice. Cytokine 124:154573","journal-title":"Cytokine"},{"issue":"1","key":"4452_CR31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00018-021-04051-x","volume":"79","author":"H Sun","year":"2021","unstructured":"Sun H, Kim E, Ryu J, Lee H, Shin EA, Lee M, Lee H, Lee JH, Yoon JH, Song DG, Kim S, Lee JW (2021) TM4SF5-mediated liver malignancy involves NK cell exhaustion-like phenotypes. Cell Mol Life Sci 79(1):49","journal-title":"Cell Mol Life Sci"},{"issue":"21\u201322","key":"4452_CR32","doi-asserted-by":"crossref","first-page":"7025","DOI":"10.1007\/s00018-021-03958-9","volume":"78","author":"MS Wegner","year":"2021","unstructured":"Wegner MS, Sch\u00f6mel N, Olzomer EM, Trautmann S, Olesch C, Byrne FL, Br\u00fcne B, Gurke R, Ferreir\u00f3s N, Weigert A, Geisslinger G, Hoehn KL (2021) Increased glucosylceramide production leads to decreased cell energy metabolism and lowered tumor marker expression in non-cancerous liver cells. Cell Mol Life Sci 78(21\u201322):7025\u20137041","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"4452_CR33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29(1):15\u201321","journal-title":"Bioinformatics"},{"issue":"7","key":"4452_CR34","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W (2014) featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30(7):923\u2013930","journal-title":"Bioinformatics"},{"issue":"5","key":"4452_CR35","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16(5):284\u2013287","journal-title":"OMICS"},{"issue":"43","key":"4452_CR36","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102(43):15545\u201315550","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"4452_CR37","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cell.2013.09.031","volume":"155","author":"G He","year":"2013","unstructured":"He G, Dhar D, Nakagawa H, Font-Burgada J, Ogata H, Jiang Y, Shalapour S, Seki E, Yost SE, Jepsen K, Frazer KA, Harismendy O, Hatziapostolou M, Iliopoulos D, Suetsugu A, Hoffman RM, Tateishi R, Koike K, Karin M (2013) Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling. Cell 155(2):384\u2013396","journal-title":"Cell"},{"issue":"6","key":"4452_CR38","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/hep.30773","volume":"70","author":"SM Siew","year":"2019","unstructured":"Siew SM, Cunningham SC, Zhu E, Tay SS, Venuti E, Bolitho C, Alexander IE (2019) Prevention of cholestatic liver disease and reduced tumorigenicity in a murine model of PFIC type 3 using hybrid AAV-piggyBac gene therapy. Hepatology 70(6):2047\u20132061","journal-title":"Hepatology"},{"key":"4452_CR39","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.7717\/peerj-cs.67","volume":"2","author":"J Anaya","year":"2016","unstructured":"Anaya J (2016) OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs. PeerJ Comput Sci 2:e67","journal-title":"PeerJ Comput Sci"},{"key":"4452_CR40","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1038\/ncomms3977","volume":"5","author":"A Parikh","year":"2014","unstructured":"Parikh A, Lee C, Joseph P, Marchini S, Baccarini A, Kolev V, Romualdi C, Fruscio R, Shah H, Wang F, Mullokandov G, Fishman D, D\u2019Incalci M, Rahaman J, Kalir T, Redline RW, Brown BD, Narla G, DiFeo A (2014) microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition. Nat Commun 5:2977","journal-title":"Nat Commun"},{"issue":"D1","key":"4452_CR41","doi-asserted-by":"crossref","first-page":"D222","DOI":"10.1093\/nar\/gkab1079","volume":"50","author":"HY Huang","year":"2022","unstructured":"Huang HY, Lin YC, Cui S, Huang Y, Tang Y, Xu J, Bao J, Li Y, Wen J, Zuo H, Wang W, Li J, Ni J, Ruan Y, Li L, Chen Y, Xie Y, Zhu Z, Cai X, Chen X, Yao L, Chen Y, Luo Y, LuXu S, Luo M, Chiu CM, Ma K, Zhu L, Cheng GJ, Bai C, Chiang YC, Wang L, Wei F, Lee TY, Huang HD (2022) miRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions. Nucleic Acids Res 50(D1):D222\u2013D230","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"4452_CR42","doi-asserted-by":"crossref","first-page":"e75104","DOI":"10.1371\/journal.pone.0075104","volume":"8","author":"L Li","year":"2013","unstructured":"Li L, Wang C, Calvisi DF, Evert M, Pilo MG, Jiang L, Yuneva M, Chen X (2013) SCD1 Expression is dispensable for hepatocarcinogenesis induced by AKT and Ras oncogenes in mice. PLoS ONE 8(9):e75104","journal-title":"PLoS ONE"},{"issue":"11","key":"4452_CR43","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1182\/blood-2004-08-2976","volume":"105","author":"T Inukai","year":"2005","unstructured":"Inukai T, Inaba T, Dang J, Kuribara R, Ozawa K, Miyajima A, Wu W, Look AT, Arinobu Y, Iwasaki H, Akashi K, Kagami K, Goi K, Sugita K, Nakazawa S (2005) TEF, an antiapoptotic bZIP transcription factor related to the oncogenic E2A-HLF chimera, inhibits cell growth by down-regulating expression of the common beta chain of cytokine receptors. Blood 105(11):4437\u20134444","journal-title":"Blood"},{"issue":"11","key":"4452_CR44","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1158\/0008-5472.CAN-07-5040","volume":"68","author":"DC Lee","year":"2008","unstructured":"Lee DC, Kang YK, Kim WH, Jang YJ, Kim DJ, Park IY, Sohn BH, Sohn HA, Lee HG, Lim JS, Kim JW, Song EY, Kim DM, Lee MN, Oh GT, Kim SJ, Park KC, Yoo HS, Choi JY, Yeom YI (2008) Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis. Cancer Res 68(11):4210\u20134220","journal-title":"Cancer Res"},{"issue":"W1","key":"4452_CR45","doi-asserted-by":"crossref","first-page":"W242","DOI":"10.1093\/nar\/gkab418","volume":"49","author":"C Li","year":"2021","unstructured":"Li C, Tang Z, Zhang W, Ye Z, Liu F (2021) GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA. Nucleic Acids Res 49(W1):W242\u2013W246","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"4452_CR46","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1074\/mcp.M500279-MCP200","volume":"4","author":"M Uhlen","year":"2005","unstructured":"Uhlen M, Bjorling E, Agaton C, Szigyarto CA, Amini B, Andersen E, Andersson AC, Angelidou P, Asplund A, Asplund C, Berglund L, Bergstrom K, Brumer H, Cerjan D, Ekstrom M, Elobeid A, Eriksson C, Fagerberg L, Falk R, Fall J, Forsberg M, Bjorklund MG, Gumbel K, Halimi A, Hallin I, Hamsten C, Hansson M, Hedhammar M, Hercules G, Kampf C, Larsson K, Lindskog M, Lodewyckx W, Lund J, Lundeberg J, Magnusson K, Malm E, Nilsson P, Odling J, Oksvold P, Olsson I, Oster E, Ottosson J, Paavilainen L, Persson A, Rimini R, Rockberg J, Runeson M, Sivertsson A, Skollermo A, Steen J, Stenvall M, Sterky F, Stromberg S, Sundberg M, Tegel H, Tourle S, Wahlund E, Walden A, Wan J, Wernerus H, Westberg J, Wester K, Wrethagen U, Xu LL, Hober S, Ponten F (2005) A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics 4(12):1920\u20131932","journal-title":"Mol Cell Proteomics"},{"issue":"5","key":"4452_CR47","doi-asserted-by":"crossref","first-page":"e98295","DOI":"10.1371\/journal.pone.0098295","volume":"9","author":"P Pallante","year":"2014","unstructured":"Pallante P, Sepe R, Federico A, Forzati F, Bianco M, Fusco A (2014) CBX7 modulates the expression of genes critical for cancer progression. PLoS ONE 9(5):e98295","journal-title":"PLoS ONE"},{"issue":"1","key":"4452_CR48","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1038\/s41467-019-09628-6","volume":"10","author":"HF Moussa","year":"2019","unstructured":"Moussa HF, Bsteh D, Yelagandula R, Pribitzer C, Stecher K, Bartalska K, Michetti L, Wang J, Zepeda-Martinez JA, Elling U, Stuckey JI, James LI, Frye SV, Bell O (2019) Canonical PRC1 controls sequence-independent propagation of Polycomb-mediated gene silencing. Nat Commun 10(1):1931","journal-title":"Nat Commun"},{"issue":"1","key":"4452_CR49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.stem.2011.12.006","volume":"10","author":"L Morey","year":"2012","unstructured":"Morey L, Pascual G, Cozzuto L, Roma G, Wutz A, Benitah SA, Di Croce L (2012) Nonoverlapping functions of the Polycomb group Cbx family of proteins in embryonic stem cells. Cell Stem Cell 10(1):47\u201362","journal-title":"Cell Stem Cell"},{"issue":"4","key":"4452_CR50","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ncb2701","volume":"15","author":"K Klauke","year":"2013","unstructured":"Klauke K, Radulovic V, Broekhuis M, Weersing E, Zwart E, Olthof S, Ritsema M, Bruggeman S, Wu X, Helin K, Bystrykh L, de Haan G (2013) Polycomb Cbx family members mediate the balance between haematopoietic stem cell self-renewal and differentiation. Nat Cell Biol 15(4):353\u2013362","journal-title":"Nat Cell Biol"},{"key":"4452_CR51","volume":"12","author":"J Li","year":"2021","unstructured":"Li J, Ouyang T, Li M, Hong T, Alriashy M, Meng W, Zhang N (2021) CBX7 is dualistic in cancer progression based on its function and molecular interactions. Front Genet 12:740794","journal-title":"Front Genet"},{"issue":"13","key":"4452_CR52","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1073\/pnas.0608721104","volume":"104","author":"CL Scott","year":"2007","unstructured":"Scott CL, Gil J, Hernando E, Teruya-Feldstein J, Narita M, Martinez D, Visakorpi T, Mu D, Cordon-Cardo C, Peters G, Beach D, Lowe SW (2007) Role of the chromobox protein CBX7 in lymphomagenesis. Proc Natl Acad Sci U S A 104(13):5389\u20135394","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"25","key":"4452_CR53","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1038\/s41388-018-0181-8","volume":"37","author":"H Ehedego","year":"2018","unstructured":"Ehedego H, Mohs A, Jansen B, Hiththetiya K, Sicinski P, Liedtke C, Trautwein C (2018) Loss of Cyclin E1 attenuates hepatitis and hepatocarcinogenesis in a mouse model of chronic liver injury. Oncogene 37(25):3329\u20133339","journal-title":"Oncogene"},{"issue":"1","key":"4452_CR54","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/j.gastro.2019.03.016","volume":"157","author":"K Aziz","year":"2019","unstructured":"Aziz K, Limzerwala JF, Sturmlechner I, Hurley E, Zhang C, Jeganathan KB, Nelson G, Bronk S, Fierro Velasco RO, van Deursen EJ, O\u2019Brien DR, Kocher JA, Youssef SA, van Ree JH, de Bruin A, van den Bos H, Spierings DCJ, Foijer F, van de Sluis B, Roberts LR, Gores GJ, Li H, van Deursen JM (2019) Ccne1 overexpression causes chromosome instability in liver cells and liver tumor development in mice. Gastroenterology 157(1):210-226.e12","journal-title":"Gastroenterology"},{"issue":"5","key":"4452_CR55","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/hep.29254","volume":"66","author":"R Desert","year":"2017","unstructured":"Desert R, Rohart F, Canal F, Sicard M, Desille M, Renaud S, Turlin B, Bellaud P, Perret C, Clement B, Le Cao KA, Musso O (2017) Human hepatocellular carcinomas with a periportal phenotype have the lowest potential for early recurrence after curative resection. Hepatology 66(5):1502\u20131518","journal-title":"Hepatology"},{"issue":"2","key":"4452_CR56","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1172\/JCI58620","volume":"122","author":"F Forzati","year":"2012","unstructured":"Forzati F, Federico A, Pallante P, Abbate A, Esposito F, Malapelle U, Sepe R, Palma G, Troncone G, Scarfo M, Arra C, Fedele M, Fusco A (2012) CBX7 is a tumor suppressor in mice and humans. J Clin Invest 122(2):612\u2013623","journal-title":"J Clin Invest"},{"issue":"5","key":"4452_CR57","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1089\/gtmb.2018.0293","volume":"23","author":"X Zhu","year":"2019","unstructured":"Zhu X, Qin M, Li C, Zeng W, Bei C, Tan C, Zhang Y, Shi W, Kong J, Fu Y, Tan S (2019) Downregulated expression of chromobox homolog 7 in hepatocellular carcinoma. Genet Test Mol Biomarkers 23(5):348\u2013352","journal-title":"Genet Test Mol Biomarkers"},{"issue":"5","key":"4452_CR58","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1631\/jzus.B1400077","volume":"15","author":"RG Ma","year":"2014","unstructured":"Ma RG, Zhang Y, Sun TT, Cheng B (2014) Epigenetic regulation by polycomb group complexes: focus on roles of CBX proteins. J Zhejiang Univ Sci B 15(5):412\u2013428","journal-title":"J Zhejiang Univ Sci B"},{"issue":"5","key":"4452_CR59","first-page":"1594","volume":"5","author":"P Pallante","year":"2015","unstructured":"Pallante P, Forzati F, Federico A, Arra C, Fusco A (2015) Polycomb protein family member CBX7 plays a critical role in cancer progression. Am J Cancer Res 5(5):1594\u20131601","journal-title":"Am J Cancer Res"},{"issue":"16","key":"4452_CR60","doi-asserted-by":"crossref","first-page":"26637","DOI":"10.18632\/oncotarget.15789","volume":"8","author":"T Yu","year":"2017","unstructured":"Yu T, Wu Y, Hu Q, Zhang J, Nie E, Wu W, Wang X, Wang Y, Liu N (2017) CBX7 is a glioma prognostic marker and induces G1\/S arrest via the silencing of CCNE1. Oncotarget 8(16):26637\u201326647","journal-title":"Oncotarget"},{"issue":"17","key":"4452_CR61","doi-asserted-by":"crossref","first-page":"7079","DOI":"10.1158\/0008-5472.CAN-09-1542","volume":"69","author":"A Federico","year":"2009","unstructured":"Federico A, Pallante P, Bianco M, Ferraro A, Esposito F, Monti M, Cozzolino M, Keller S, Fedele M, Leone V, Troncone G, Chiariotti L, Pucci P, Fusco A (2009) Chromobox protein homologue 7 protein, with decreased expression in human carcinomas, positively regulates E-cadherin expression by interacting with the histone deacetylase 2 protein. Cancer Res 69(17):7079\u20137087","journal-title":"Cancer Res"},{"issue":"20","key":"4452_CR62","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1038\/s41388-020-1269-5","volume":"39","author":"J Li","year":"2020","unstructured":"Li J, Alvero AB, Nuti S, Tedja R, Roberts CM, Pitruzzello M, Li Y, Xiao Q, Zhang S, Gan Y, Wu X, Mor G, Yin G (2020) CBX7 binds the E-box to inhibit TWIST-1 function and inhibit tumorigenicity and metastatic potential. Oncogene 39(20):3965\u20133979","journal-title":"Oncogene"},{"issue":"3","key":"4452_CR63","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1053\/j.gastro.2019.05.001","volume":"157","author":"S Caruso","year":"2019","unstructured":"Caruso S, Calatayud AL, Pilet J, La Bella T, Rekik S, Imbeaud S, Letouze E, Meunier L, Bayard Q, Rohr-Udilova N, Peneau C, Grasl-Kraupp B, de Koning L, Ouine B, Bioulac-Sage P, Couchy G, Calderaro J, Nault JC, Zucman-Rossi J, Rebouissou S (2019) Analysis of liver cancer cell lines identifies agents with likely efficacy against hepatocellular carcinoma and markers of response. Gastroenterology 157(3):760\u2013776","journal-title":"Gastroenterology"},{"issue":"4","key":"4452_CR64","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1172\/JCI129012","volume":"130","author":"K Valencia","year":"2020","unstructured":"Valencia K, Erice O, Kostyrko K, Hausmann S, Guruceaga E, Tathireddy A, Flores NM, Sayles LC, Lee AG, Fragoso R, Sun TQ, Vallejo A, Roman M, Entrialgo-Cadierno R, Migueliz I, Razquin N, Fortes P, Lecanda F, Lu J, Ponz-Sarvise M, Chen CZ, Mazur PK, Sweet-Cordero EA, Vicent S (2020) The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas. J Clin Invest 130(4):1879\u20131895","journal-title":"J Clin Invest"},{"key":"4452_CR65","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/cancers13215583","volume":"13","author":"GR Romualdo","year":"2021","unstructured":"Romualdo GR, Leroy K, Costa CJS, Prata GB, Vanderborght B, da Silva TC, Barbisan LF, Andraus W, Devisscher L, C\u00e2mara NOS, Vinken M, Cogliati B (2021) In vivo and in vitro models of hepatocellular carcinoma: current strategies for translational modeling. Cancers (Basel) 13:21","journal-title":"Cancers (Basel)"},{"issue":"2","key":"4452_CR66","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jhep.2020.04.011","volume":"73","author":"YA Nevzorova","year":"2020","unstructured":"Nevzorova YA, Boyer-Diaz Z, Cubero FJ, Gracia-Sancho J (2020) Animal models for liver disease\u2014a practical approach for translational research. J Hepatol 73(2):423\u2013440","journal-title":"J Hepatol"},{"issue":"2","key":"4452_CR67","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3727\/105221620X15913805462476","volume":"20","author":"SP Monga","year":"2020","unstructured":"Monga SP (2020) Inside-out or outside-in: choosing the right model of hepatocellular cancer. Gene Expr 20(2):139\u2013145","journal-title":"Gene Expr"},{"issue":"12","key":"4452_CR68","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/onc.2010.531","volume":"30","author":"Y Wang","year":"2011","unstructured":"Wang Y, Yu Y, Tsuyada A, Ren X, Wu X, Stubblefield K, Rankin-Gee EK, Wang SE (2011) Transforming growth factor-beta regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM. Oncogene 30(12):1470\u20131480","journal-title":"Oncogene"},{"key":"4452_CR69","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.jid.2021.09.040","volume":"142","author":"V Chitsazzadeh","year":"2021","unstructured":"Chitsazzadeh V, Nguyen TN, de Mingo Pulido A, Bittencourt BB, Du L, Adelmann CH, Ortiz Rivera I, Nguyen KA, Guerra LD, Davis A, Napoli M, Ma W, Davis RE, Rajapakshe K, Coarfa C, Flores ER, Tsai KY (2021) miR-181a promotes multiple protumorigenic functions by targeting TGF\u03b2R3. J Invest Dermatol 142:1956\u20131965","journal-title":"J Invest Dermatol"},{"issue":"1","key":"4452_CR70","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2045-3701-1-4","volume":"1","author":"J Ji","year":"2011","unstructured":"Ji J, Yamashita T, Wang XW (2011) Wnt\/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma. Cell Biosci 1(1):4","journal-title":"Cell Biosci"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04452-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-022-04452-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04452-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T14:52:45Z","timestamp":1661179965000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-022-04452-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":70,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["4452"],"URL":"https:\/\/doi.org\/10.1007\/s00018-022-04452-6","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]},"assertion":[{"value":"24 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors who have taken part in this study declared that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"In accordance with the New South Wales Animal Research Act of 1985, animal experimental protocols had been approved by the Sydney Local Health District Animal Welfare Committee (Protocol No 2018\/016). All experiments were conducted in accordance with the National Health and Medical Research Council\u2019s Australian Code of Practice for the Care and Use of Animals for Scientific Purposes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}}],"article-number":"443"}}